Prim, a listed company specializing in medical technology and healthcare and mobility solutions, has set a goal of reaching sales of 500 million euros and increasing its Ebitda to 81 million within its 2026-2031 strategic plan, presented this Thursday at its "Investor Day".
The program, dubbed "#LoQueNosImpulsa", marks a six-year roadmap to "continue transforming" the company and position it in 2031 at 500 million euros in revenue and 81 million in Ebitda, compared to 252 million in sales and 34 million in Ebitda recorded in 2025, which implies doubling revenue and more than doubling operating profit.
As the company has communicated to the National Securities Market Commission (CNMV), this new plan is based on the lessons learned and the achievements of the previous strategic plan, concluded in 2025, a year in which Prim achieved its best results in the last five years.
Two phases to consolidate and accelerate growth
The plan's design includes two main stages. The first, between 2026 and 2028, is oriented towards business consolidation through margin improvement, integration of recent acquisitions, and optimization of operational efficiency.
The second phase, from 2029 to 2031, focuses on accelerating growth and reinforcing European leadership in its main segments. "#LoQueNosImpulsa" is also structured around four strategic pillars: strengthening the 'core' in medical technologies and healthcare and mobility; operating with excellence to generate more cash; transforming value through selective acquisitions and new business models; and leveraging talent as a sustainable competitive advantage.
Organic growth is complemented by an investment plan that will continue to rely on inorganic growth as an additional lever for the project. "Each operation will have a clear strategic fit within the Medical Technology (MT) or Healthcare and Mobility Solutions (HMS) platforms, with discipline in the required return," the company explained.
Growing and sustainable dividend policy
For Prim's executive director, Fernando Oliveros, "the plan is designed to continue growing and improving profitability and cash generation, while strengthening leadership in the Spanish and European market, financing our growth with our own business generation and the efficient use of financial debt to accelerate our scale," he stated.
In the area of shareholder remuneration, the company will maintain its policy of a "growing and sustainable" dividend, setting the floor at the amount paid in 2025, which is 0.47 euros per share, equivalent to a 'payout' of 54%. Furthermore, Prim has specified that, in stages of greater inorganic growth intensity, the 'payout' will be adjusted within the foreseen range, without the dividend being reduced in absolute terms under any circumstances.
Along these lines, the president of Prim, Lucía Comenge, has conveyed to analysts and investors that they "are experiencing the most transformative moment in their recent history." "The new strategic plan reinforces our ability to grow and, at the same time, to continue rewarding shareholders," she added, emphasizing that this combination is what "has always defined Prim and has allowed them to become a safe bet."
The "Investor Day" featured the participation of the company's president, the vice president, Jorge Prim, the executive director, the head of ESG policies, Cristina de Andúaga, the corporate manager of talent and culture, Susana Rodado, and the head of investor relations and mergers and acquisitions, Tello González de Aguilar.